Effects of glucagon on the redox states of cytochromes in mitochondria in situ in perfused rat liver

The effects of glucagon on the respiratory function of mitochondria in situ were investigated in isolated perfused rat liver. Glucagon at the concentrations higher than 20 pM and cyclic AMP (75 microM) stimulated hepatic respiration, and shifted the redox state of pyridine nucleotide (NADH/NAD) in mitochondria in situ to a more reduced state as judged by organ fluorometry and beta-hydroxybutyrate/acetoacetate ratio. The organ spectrophotometric study revealed that glucagon and cyclic AMP induced the reduction of redox states of cytochromes a(a3), b and c+c1. Atractyloside (4 micrograms/ml) abolished the effects of glucagon on these parameters and gluconeogenesis from lactate. These observations suggest that glucagon increases the availability of substrates for mitochondrial respiration, and this alteration in mitochondrial function is crucial in enhancing gluconeogenesis.     

Comparison of ESR1 Mutations in Tumor Tissue and Matched Plasma Samples from Metastatic Breast Cancer Patients

BACKGROUND: ESR1 mutation in circulating cell-free DNA (cfDNA) is emerging as a noninvasive biomarker of acquired resistance to endocrine therapy, but there is a paucity of data comparing the status of ESR1 gene in cfDNA with that in its corresponding tumor tissue. The objective of this study is to validate the degree of concordance of ESR1 mutations between plasma and tumor tissue. METHODS: ESR1 ligand-binding domain mutations Y537S, Y537N, Y537C, and D538G were analyzed using droplet digital PCR in 35 patients with metastatic breast cancer (MBC) (35 tumor tissue samples and 67 plasma samples). RESULTS: Of the 35 paired samples, 26 (74.3%) were concordant: one patient had detectable ESR1 mutations both plasma (ESR1 Y537S/Y537N) and tumor tissue (ESR1 Y537S/Y537C), and 25 had WT ESR1 alleles in both. Nine (25.7%) had discordance between the plasma and tissue results: five had mutations detected only in their tumor tissue (two Y537S, one Y537C, one D538G, and one Y537S/Y537N/D538G), and four had mutations detected only in their plasma (one Y537S, one Y537N, and two Y537S/Y537N/D538G). Furthermore, longitudinal plasma samples from 19 patients were used to assess changes in the presence of ESR1 mutations during treatment. Eleven patients had cfDNA ESR1 mutations over the course of treatment. A total of eight of 11 patients with MBC with cfDNA ESR1 mutations (72.7%) had the polyclonal mutations. CONCLUSION: We have shown the independent distribution of ESR1 mutations between plasma and tumor tissue in 35 patients with MBC.     

Stimulation of hepatic glycogenolysis by 12-O-tetradecanoylphorbol-13-acetate (TPA) via a calcium requiring process

12-O-Tetradecanoylphorbol-13-acetate (TPA) stimulated glycogenolysis in perfused rat liver which was perfused with Krebs-Ringer-bicarbonate buffer containing 1 mM CaCl2 but no substrate. Verapamil (100 microM), diltiazem (100 microM) and trifluoperazin (100 microM), all inhibited the effect of TPA in the presence of CaCl2. Omission of CaCl2 from the perfusate or the addition of EGTA markedly attenuated the effect of TPA. TPA decreased net release of 45Ca from 45Ca-preloaded liver. The effect of maximal concentration of TPA (20 ng/ml) was not additive to that of 0.6 microM A23187. These data suggest that TPA increases calcium influx into hepatocytes and stimulates glycogenolysis through a calcium-calmodulin dependent mechanism.     

Distribution of histone F1 on calf thymus nucleohistone DNA.

A method of large-scale preparation of the histone F1-DNA complex by removing all other proteins from calf thymus nucleohistone was established. This involved gel filtration of nucleohistone through a column containing a band of sodium dodecyl sulfate. The F1-DNA complex obtained had the original amount of F1 and no other. The F1-DNA complex exhibited distinct two-step melting on thermal denaturation. The first step was apparently attributable to naked DNA regions and the second step, about 30 deg. C higher than the first step, to the regions covered with F1. Buoyant density experiments with the complex after fixation with formalin revealed that F1 was distributed fairly evenly over DNA fragments of an average molecular weight of about 4 × 10⁶. Electron microscopic examination of the complex after various degrees of denaturation with formalin indicated that the longest stretch of unbound DNA was about 0·3 μm.     

Prolactin receptor.

The importance of prolactin receptor as an index of prolactin responsiveness of target organs has been of much interest in recent years. In this review, the literature on prolactin receptor studies is surveyed from the view point of the existence, properties and regulation of the receptor. Some special attention has been attached to the studies dealing with the significance of prolactin receptor as a monitoring model in predicting mammary tumor responsiveness to prolactin.     

Discovery of a novel orally active TRPV4 inhibitor: Part 1. Optimization from an HTS hit

1. Download : Download high-res image (72KB)
2. Download : Download full-size image

     

A rapid determination of sodium dodecyl sulfate with methylene blue.

A rapid procedure of sodium dodecyl sulfate determination was established. The method is sensitive (0–6 μg of SDS), accurate, easy to operate and uninfluenced by the presence of protein. The method is a modification of Mukerjee's that takes advantage of water-insoluble salt formation between the detergent and methylene blue, which was extracted by chloroform. Absorbance was measured in a test-tube-push-in type spectrophotometer (Bausch and Lomb Spectronic 20) with an aqueous layer on top of the chloroform; thus evaporation of chloroform was avoided and steps for removal of the aqueous phase and transfer of chloroform to cuvettes were omitted to greatly abbreviate the whole procedure.     

The levels of three enolase subunits in human tumors; a low α-/γ-subunit ratio as indicator of tumors of neuronal and neuroendocrine nature

The contents of three subunits (α, β and γ) of enolase isoenzymes of various human tumors, especially of neuronal and neuroendocrine tumors, were determined by a highly sensitive enzyme immunoassay system. A high level of γ-subunit was detected in neuronal and neuroendocrine tumors, including small cell carcinomas of the lung. The level of α-subunit was generally higher in all tumors and varied according to the tumor. The β-subunit level was elevated in rhabdomyosarcomas. Furthermore, analyzing the relationship between the contents of each enolase subunit among the tumors, the α-/γ-subunit ratios were the lowest in neuronal tumors and increased in order of neuroendocrine and non-neuroendocrine tumors. This result suggested that the α-/γ-subunit ratio is an important indicator to evaluate neuronal and neuroendocrine differentiation of the tumor rather than the amount of γ-subunit of enolase itself.